Literature DB >> 17483695

Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome.

Shen Qu1, Weidong Le, Xiong Zhang, Wenjie Xie, Aijun Zhang, William G Ondo.   

Abstract

Restless legs syndrome (RLS) is a common neurologic condition involving iron and dopamine systems. We sought to create an animal model consistent with RLS based on current understanding of human pathology. We performed bilateral 6-hydroxydopamine (6-OHDA) lesioning in the A11 nucleus of C57BL/6 mice and deprived a subset of mice from dietary iron to observe whether these manipulations can increase motor activity. Iron levels in serum, brain, and especially spinal cord were significantly decreased after iron deprivation. Interestingly, 6-OHDA lesioning appeared to further reduce CNS iron stores. Pathologic examination demonstrated a 94% reduction in A11 tyrosine hydroxylase staining cells in mice injected with 6-OHDA but minimal effects on other areas. Locomotor activities were significantly increased in both the mice that were iron deprived and the A11-lesioned mice compared with controls. The combination of iron deprivation and A11 lesions further significantly augmented activity. Additionally, the mice in the combined iron-deprived and lesioned group were more aggressive. The increased activity in A11-lesioned mice with or without iron deprivation was normalized after treatment with the D2/D3 agonist ropinirole, as is seen in human RLS but was worsened by the D1 agonist SKF38393. This model could be consistent with human RLS, attention deficit hyperactivity disorder, or akathisia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483695     DOI: 10.1097/nen.0b013e3180517b5f

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  35 in total

Review 1.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

Review 2.  An update on the pathophysiology and genetics of restless legs syndrome.

Authors:  Lynn Marie Trotti; Srinivas Bhadriraju; David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

Review 3.  Pathophysiology of restless legs syndrome: evidence for iron involvement.

Authors:  James R Connor
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

Review 4.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

5.  Restless legs syndrome: pathophysiology and treatment.

Authors:  William G Ondo
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

6.  The conserved dopaminergic diencephalospinal tract mediates vertebrate locomotor development in zebrafish larvae.

Authors:  Aaron M Lambert; Joshua L Bonkowsky; Mark A Masino
Journal:  J Neurosci       Date:  2012-09-26       Impact factor: 6.167

Review 7.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

8.  BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Atbin Doroodchi; Hong Xing; Yi Sheng; Mark P DeAndrade; Youfeng Yang; Tracy L Johnson; Stefan Clemens; Fumiaki Yokoi; Michael A Miller; Rui Xiao; Yuqing Li
Journal:  Brain Struct Funct       Date:  2020-05-28       Impact factor: 3.270

9.  Deficiency of Meis1, a transcriptional regulator, in mice and worms: Neurochemical and behavioral characterizations with implications in the restless legs syndrome.

Authors:  Shangru Lyu; Hong Xing; Yuning Liu; Pallavi Girdhar; Keer Zhang; Fumiaki Yokoi; Rui Xiao; Yuqing Li
Journal:  J Neurochem       Date:  2020-09-23       Impact factor: 5.372

10.  Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice.

Authors:  Matthew A Stroh; Michelle K Winter; Russell H Swerdlow; Kenneth E McCarson; Hao Zhu
Journal:  Metab Brain Dis       Date:  2016-05-18       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.